Seeking Alpha

  Geron Corporation - NASDAQ

10/23/2014, 12:32 AM ET
  • StockConsultant | Send Message 30 Jun

    $GERN intra day spike now back on watch for a 3.29 flag breakout,
      GERN vs. ETF Alternatives
      Company Description
      Geron Corp is a clinical stage biopharmaceutical company engaged in the discovery and development of therapeutic products for oncology such as telomerase inhibitor, imetelstat and in hematologic myeloid malignancies, among others.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States